Search
Merck & Co Inc
MRKAdd to Watchlist
148.970USD
+2.100+1.43%
Market hours 09/21, 11:06（ET）
367.75BMarket Cap
41.76P/E TTM
Merck & Co Inc (MRK) Stock Price Target & Forecast
Analyst Rating
Based on 32 analysts giving stock ratings to Merck & Co Inc in the past month.
Buy
8 Strong Buy
14 Buy
10 Hold
0 Sell
0 Strong Sell
Target Price
150.845USD+2.51%
MRK Analyst Recommendation Trends
In the current month, MRK has received 14 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. MRK average Analyst price target in the last month is 150.845.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
8
8
7
7
7
7
6
6
14
14
15
14
14
11
13
12
10
10
9
10
11
12
11
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
32
31
31
32
30
30
30
MRK Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Pfizer Inc
PFE
5
6
19
1
1
32
Bristol-Myers Squibb Co
BMY
5
6
18
2
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, MRK EPS is projected to reach 2.193 in FY2026Q3, following reported EPS of -0.540 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.01
-1.51
-0.27
2.19
1.96
Actual
1.19
-1.72
-0.54
--
--
Surprise
-40.57%
-13.69%
-100.18%
--
--
FAQs
What is Merck & Co Inc's expected revenue for the next quarter?
Merck & Co Inc's expected revenue is 17.28B.
What is Merck & Co Inc's price target?
Analysts forecast that Merck & Co Inc's price target is USD 150.85, with the highest forecast at USD 186.00 and the lowest forecast at USD 105.00.
How have Merck & Co IncMRK's recent earnings per share performed?
The market expectation was USD -0.54, while Merck & Co IncMRK's earnings per share (EPS) for the previous quarter was USD -1.72. EPS for the next quarter is expected at USD 2.19.
What is the analyst rating for Merck & Co Inc?
Based on the ratings of Merck & Co Inc's stock from 32 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.